X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (173) 173
alzheimer's disease (151) 151
humans (149) 149
florbetapir (134) 134
mild cognitive impairment (129) 129
pet (107) 107
dementia (102) 102
aged (100) 100
male (100) 100
female (98) 98
florbetapir f 18 (92) 92
amyloid (91) 91
alzheimers-disease (89) 89
neurosciences (87) 87
positron-emission-tomography (87) 87
positron-emission tomography (85) 85
alzheimer disease - diagnostic imaging (77) 77
clinical neurology (68) 68
brain - diagnostic imaging (65) 65
diagnosis (61) 61
positron emission tomography (61) 61
aged, 80 and over (58) 58
radiology, nuclear medicine & medical imaging (58) 58
brain (55) 55
middle aged (54) 54
pittsburgh compound-b (54) 54
alzheimer’s disease (51) 51
biomarkers (51) 51
neurology (47) 47
aniline compounds (46) 46
magnetic resonance imaging (46) 46
ethylene glycols (45) 45
neuroimaging (45) 45
pet imaging (45) 45
positron-emission tomography - methods (43) 43
national institute (40) 40
alzheimer disease - metabolism (39) 39
amyloid - metabolism (39) 39
article (39) 39
amyloid beta-peptides - metabolism (38) 38
radiopharmaceuticals (38) 38
brain - metabolism (37) 37
medicine & public health (35) 35
pathology (33) 33
deposition (32) 32
nuclear medicine (32) 32
cognitive dysfunction - diagnostic imaging (30) 30
alzheimers disease (29) 29
medical imaging (28) 28
tomography (27) 27
alzheimer disease - pathology (26) 26
alzheimer disease (25) 25
amyloid pet (25) 25
cognitive ability (25) 25
diagnostic guidelines (25) 25
florbetapir-pet (25) 25
geriatrics & gerontology (25) 25
a-beta (24) 24
alzheimer disease - diagnosis (24) 24
amyloid imaging (24) 24
imaging / radiology (23) 23
brain - pathology (22) 22
mental disorders (22) 22
neuropsychological tests (22) 22
beta (21) 21
disease progression (21) 21
f 18 (21) 21
amyloidosis (20) 20
cerebrospinal fluid (20) 20
in-vivo (20) 20
memory (20) 20
positron emission (20) 20
cardiology (19) 19
oncology (19) 19
orthopedics (19) 19
quantification (19) 19
amyloid-beta (18) 18
animals (18) 18
diagnostic imaging (18) 18
fdg-pet (18) 18
disease (17) 17
usage (17) 17
β-amyloid (17) 17
original (16) 16
plaques (16) 16
aging (15) 15
cognitive dysfunction - metabolism (15) 15
cortex (15) 15
mci (15) 15
mri (15) 15
plaque, amyloid - diagnostic imaging (15) 15
psychiatry (15) 15
aniline compounds - metabolism (14) 14
association workgroups (14) 14
atrophy (14) 14
beta-amyloid (14) 14
biomarker (14) 14
fluorodeoxyglucose f18 (14) 14
impairment (14) 14
neurodegenerative diseases (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2015, Volume 11, Issue 12, pp. 1417 - 1429
Abstract Introduction This study assessed apolipoprotein E ( APOE ) ε4 carrier status effects on Alzheimer's disease imaging and cerebrospinal fluid (CSF)... 
Neurology | Neuroimaging | ADNI | SMC | FDG | Cerebrospinal fluid | Significant memory concern | Alzheimer's Disease Neuroimaging Initiative | Subjective cognitive decline | SCD | Apolipoprotein E | [18F]Florbetapir PET | CSF | APOE | PET | [18F]Fluorodeoxyglucose | Structural magnetic resonance imaging (MRI) | F]Fluorodeoxyglucose | F]Florbetapir PET | SURFACE-BASED ANALYSIS | BRAIN ATROPHY | COMPLAINTS | DEMENTIA | NEUROIMAGING INITIATIVE ADNI | [F-18] Florbetapir PET | PATHOLOGY | CLINICAL NEUROLOGY | APOLIPOPROTEIN-E | VOLUME LOSS | [F-18] Fluorodeoxyglucose | MILD COGNITIVE IMPAIRMENT | GLUCOSE-METABOLISM | Apolipoprotein E4 - genetics | Humans | Genotype | Male | Positron-Emission Tomography | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Healthy Volunteers | Alzheimer Disease - pathology | Brain - metabolism | Neuropsychological Tests | Magnetic Resonance Imaging | Alzheimer Disease - metabolism | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Brain - pathology | Adult | Female | Heterozygote | Aged | Cognitive Dysfunction - diagnosis | Biomarkers - cerebrospinal fluid | Memory - physiology | Medical colleges | Molecular genetics | Apolipoproteins | Biological markers | Alzheimer's disease | 60 APPLIED LIFE SCIENCES
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2016, Volume 43, Issue 7, pp. 1304 - 1314
We investigated dual-phase 18F-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in... 
Alzheimer’s disease | Mild cognitive impairment | Oncology | Perfusion deficits | 18 F-Florbetapir (AV-45/Amyvid) | Medicine & Public Health | Orthopedics | Amyloid | Nuclear Medicine | Imaging / Radiology | Cardiology | Dual-phase scan | Dementia | F-Florbetapir (AV-45/Amyvid)
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 11/2019, Volume 39, Issue 11, pp. 2172 - 2180
Accumulation of amyloid beta can be visualized using [18F]florbetapir positron emission tomography. The aim of this study was to identify the optimal model for... 
tracer kinetic modelling | Amyloid positron emission tomography | test–retest | [ | Alzheimer’s disease | F]florbetapir
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 04/2015, Volume 56, Issue 4, pp. 567 - 574
The accurate measurement of beta-amyloid (A beta) change using amyloid PET imaging is important for Alzheimer disease research and clinical trials but poses... 
amyloid | PET imaging | ALZHEIMERS-DISEASE | DEPOSITION | QUANTIFICATION | MILD COGNITIVE IMPAIRMENT | RADIOTRACERS | Alzheimer's disease | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PITTSBURGH COMPOUND-B | FLORBETAPIR F 18 | DECLINE
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 6/2016, Volume 43, Issue 6, pp. 1067 - 1076
The objective of this study was to evaluate the amyloid burden, as assessed by 18F-florbetapir (AV-45/Amyvid) positron emission tomography PET, in patients... 
Medicine & Public Health | Alzheimer’s disease | Mild cognitive impairment | Orthopedics | Oncology | Amyloid | Nuclear Medicine | Imaging / Radiology | Cardiology | Major depressive disorder | 18 F-Florbetapir (AV-45/Amyvid) | Dementia | F-Florbetapir (AV-45/Amyvid)
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 09/2014, Volume 41, Issue 9, pp. 1652 - 1662
Purpose Cardiac amyloidosis, a restrictive heart disease with high mortality and morbidity, is underdiagnosed due to limited targeted diagnostic imaging. The... 
Heart | FLORBETAPIR F-18 | SCINTIGRAPHY | MAGNETIC-RESONANCE | Amyloidosis | Diagnosis | AL AMYLOIDOSIS | Positron emission tomography | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | F-18-Florbetapir
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 12/2019, Volume 84, pp. 61 - 69
It remains unclear whether benzodiazepines (BZDs) constitute a risk factor for Alzheimer's disease (AD). In this study, we investigated associations between... 
Amyloid | Florbetapir | Positron emission tomography | Alzheimer's disease | GABA-A | Benzodiazepine | Life Sciences
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 02/2016, Volume 43, Issue 2, pp. 374 - 385
Imaging or tissue biomarker evidence has been introduced into the core diagnostic pathway for Alzheimer's disease (AD). PET using F-18-labelled beta-amyloid... 
CRITERIA | AUTOPSY | Florbetapir | DEMENTIA | PLAQUES | Flutemetamol | MILD COGNITIVE IMPAIRMENT | Florbetaben | TASK-FORCE | RECOMMENDATIONS | Amyloid | Alzheimer's disease | BINDING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET
Journal Article
Medecine Nucleaire, ISSN 0928-1258, 05/2017, Volume 41, Issue 3, pp. 166 - 166
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2/2016, Volume 43, Issue 2, pp. 374 - 385
Imaging or tissue biomarker evidence has been introduced into the core diagnostic pathway for Alzheimer’s disease (AD). PET using 18F-labelled beta-amyloid PET... 
Florbetaben | Florbetapir | Medicine & Public Health | Alzheimer’s disease | Orthopedics | Oncology | Amyloid | Nuclear Medicine | Imaging / Radiology | Cardiology | Flutemetamol | PET | Review
Journal Article
NeuroImage: Clinical, ISSN 2213-1582, 2013, Volume 2, Issue 1, pp. 497 - 511
Amyloid imaging is currently introduced to the market for clinical use. We will review the evidence demonstrating that the different amyloid PET ligands that... 
Clinic | PIB | Florbetaben | Diagnostic | Florbetapir | Flutemetamol | GRAY-MATTER LOSS | MILD COGNITIVE IMPAIRMENT | FRONTOTEMPORAL LOBAR DEGENERATION | NEUROIMAGING | PITTSBURGH COMPOUND-B | FLORBETAPIR F 18 | VOXEL-BASED MORPHOMETRY | POSITRON-EMISSION-TOMOGRAPHY | POSTERIOR CORTICAL ATROPHY | IN-VIVO | CEREBROSPINAL-FLUID MARKERS
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 07/2018, Volume 45, Issue 7, pp. 1129 - 1138
Purpose 18F-Florbetapir has been reported to show cardiac uptake in patients with systemic light-chain amyloidosis (AL). This study systematically assessed... 
Amyloid | Florbetapir | TTR | AL | PET | Cardiac amyloid | Heart | Spleen | Image resolution | Tongue | Positron emission | Transthyretin | Muscles | Mastication | Fluorine isotopes | Scintigraphy | SAP protein | Patients | Sensitivity | Lungs | Computed tomography | Tomography | Infiltration | Amyloidosis | Heart diseases | Deposition | Amyloid P component
Journal Article